OMCL
Omnicell, Inc. · NASDAQ
- Sector Technology Services
- Industry Information Technology Services
- Website omnicell.com
- Employees(FY) 3890
- ISIN US68213N1090
Performance
+3.08%
1W
+18.67%
1M
+28.4%
3M
+65.48%
6M
+33.24%
YTD
+62.16%
1Y
Profile
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based nexus of solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Santa Clara, California.
Technical Analysis of OMCL 2024-11-08
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-06 12:20
- 2024-11-05 19:00
OMCL: Raising target price to $52.00(Argus Research)
- 2024-11-02 09:18
Omnicell Third Quarter 2024 Earnings: EPS Beats Expectations(Simply Wall St.)
- 2024-11-01 09:15
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)(Simply Wall St.)
- 2024-10-31 12:49
- 2024-10-31 09:15
- 2024-10-31 08:01
- 2024-10-31 07:00
- 2024-10-30 16:25
Omnicell Catapults And Breaks Out After Obliterating Profit Expectations(Investor's Business Daily)
- 2024-10-30 13:45
Top Midday Gainers(MT Newswires)
- 2024-10-30 09:23
- 2024-10-30 06:41
Omnicell: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-10-30 06:30
Omnicell Announces Third Quarter 2024 Results(Business Wire)
- 2024-10-29 19:45
Omnicell (OMCL) Beats Q3 Earnings and Revenue Estimates(Yahoo Finance)
- 2024-10-29 18:30
Omnicell Announces Third Quarter 2024 Results(Businesswire)
- 2024-10-29 04:04
- 2024-10-28 12:23
- 2024-10-11 12:14
- 2024-10-08 20:00
OMCL: Raising target price to $45.00(Argus Research)
- 2024-10-07 17:35
- 2024-10-07 05:35
- 2024-10-04 12:00
- 2024-10-04 10:15
- 2024-09-25 16:15
Omnicell Names Nnamdi Njoku COO(MT Newswires)
- 2024-09-25 16:01
- 2024-09-25 04:01
- 2024-09-22 09:12
- 2024-09-11 08:56
- 2024-08-28 12:20
- 2024-08-27 20:00
OMCL: Raising target price to $36.00(Argus Research)
Page 1 of 8
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.